Andelyn Biosciences

Not all plasmids are created equal. Choosing the right grade and design can make or break your gene therapy development timeline. From research-grade to cGMP, each plasmid type comes with unique regulatory and performance considerations that, if overlooked, can lead to costly delays. In our latest newsletter, we break down key strategies for plasmid optimization, including:
 - How plasmid grade impacts cost, risk, and regulatory approval
 - The role of backbone size, selectable markers, and regulatory sequences
 - Best practices for ensuring high-yield, high-purity viral vector production Watch the featured webinar here: https://buff.ly/4gEKFiz Sign up for our newsletter today to stay ahead with expert-driven solutions: https://buff.ly/3ZRv6zl #AndelynBiosciences #GeneTherapy #PlasmidDevelopment #Newsletter

Today, we celebrate the International Day of Women and Girls in Science! At Andelyn Biosciences, we are proud to champion the incredible contributions of women in science, technology, engineering, and medicine (STEM). Their passion, innovation, and expertise drive breakthroughs in gene therapy and pave the way for a healthier future. This day is not just a celebration but a reminder of the importance of empowering and supporting women and girls in their pursuit of STEM careers. Together, we can create an inclusive environment where everyone has the opportunity to thrive and make an impact. To all the inspiring women in science... Thank you for shaping the future, one discovery at a time. Let’s continue breaking barriers and building a world full of possibilities! Who are the women in science who inspire you? Tag them in the comments and share their amazing contributions! #WomenInScience #STEM #InternationalDayOfWomenAndGirlsInScience #AndelynBiosciences #InspirationInInnovation

Innovation thrives when diverse minds come together. At Andelyn Biosciences, we believe that the next breakthrough in gene therapy will come from an environment that fosters inclusion, creativity, and representation. For generations, Black scientists and medical pioneers have advanced healthcare in ways that continue to impact lives today. From Dr. Charles Drew, whose work in blood plasma storage revolutionized transfusions, to Dr. Kizzmekia Corbett, whose research helped develop life-saving vaccines, Black innovators have pushed the boundaries of medicine and biotechnology. This Black History Month, we celebrate the Black researchers, scientists, and professionals shaping the future of gene therapy. Their contributions help ensure that life-changing therapies reach all patients in need. Diversity isn’t just important... it’s essential to driving innovation. Together, we can break barriers, uplift talent, and transform healthcare for all. Who inspires you in STEM? Let’s honor them together. #BlackHistoryMonth #STEMLeadership #GeneTherapy #DiversityInSTEM #AndelynBiosciences

Time is Running Out—Vote for Cyrill Kellerhals Today! There’s still time to support Cyrill Kellerhals, COO of Andelyn Biosciences, in his journey to becoming a 2025 Top 100 COO Award Winner! Cyrill’s visionary leadership has been instrumental in shaping the future of gene therapy manufacturing, driving innovation, and making a lasting impact in the biotech industry. Let’s help him secure this recognition! Cast your vote here: https://buff.ly/4gQ068N Voting closes February 15th, so don’t miss this chance to show your support! Thank you to everyone who has already voted—we appreciate you! #COOLeadership #Top100COO #BiotechInnovation #VoteNow #AndelynBiosciences 

Faster Timelines. Lower Costs. Reliable Results. Achieving success in gene therapy manufacturing isn’t just about hitting milestones—it’s about how efficiently and predictably you can get there. At Andelyn Biosciences, we’ve built a platform that prioritizes speed, quality, and flexibility, all while keeping costs in check. In our latest newsletter, we share how leveraging standardization and process optimization can dramatically improve your project outcomes:
 - Streamlined regulatory and CMC processes with consistent platforms
 - Configurable manufacturing to meet your unique needs
 - Up to 8x productivity gains and a 50% reduction in purification losses with DOE principles Ready to unlock smarter, faster solutions for your gene therapy development? Sign up for our newsletter today and learn how our proven approach can transform your timelines and budget: https://buff.ly/3ZRv6zl #AndelynBiosciences #AAVCuratorPlatform #GeneTherapy #Biomanufacturing #ProcessOptimization #Newsletter

Innovative therapies require precision and expertise. The AAV Curator™ Platform at Andelyn Biosciences is your trusted partner in delivering high-quality AAV vectors, from preclinical to commercial stages. Our science empowers your vision. Let’s accelerate together: https://buff.ly/4fdrqwO #AndelynBiosciences #GeneTherapy #AAVCuratorPlatform #CDMO

Today, we honor the life and legacy of Dr. Martin Luther King Jr., a visionary whose dream of equality and justice continues to inspire us. At Andelyn Biosciences, we see the power of dreams every day in our work to develop life-changing gene therapies. Like Dr. King, we believe in breaking barriers and creating opportunities—not just in science, but in life. Dr. King taught us that progress comes from collaboration and courage. His words remind us that innovation is most meaningful when it serves the greater good. This MLK Day, we recommit ourselves to advancing scientific breakthroughs that bring hope and health to communities everywhere. Let’s honor Dr. King’s legacy by daring to imagine, innovate, and act boldly for a better tomorrow. #AndelynBiosciences #Innovation #MLKDay2025 #EqualityForAll #BeTheChange

Vote for Cyrill Kellerhals! We’re thrilled to share that Cyrill Kellerhals, COO of Andelyn Biosciences, has been named a finalist for the prestigious 2025 Top 100 COO Award! This recognition highlights his exceptional leadership and unwavering commitment to advancing innovative gene therapy solutions that change lives. Your support can help Cyrill secure this well-deserved honor! Cast your vote here: https://lnkd.in/gkKzwSki
 Voting closes February 15th, so don’t wait—join us in celebrating Cyrill’s incredible impact on the biotech industry. #COOLeadership #Top100COO #BiotechInnovation #GeneTherapy #AndelynBiosciences

When choosing a CDMO for AAV manufacturing, asking the right questions can make all the difference. From assessing GMP batch experience to understanding regulatory and CMC expertise, there’s a lot to consider—but knowing where to start can feel overwhelming. In our latest email newsletter, we guide you through the critical questions to ask when evaluating manufacturing platforms, including: How to assess a CDMO's AAV manufacturing track record - Key performance metrics like yields and regulatory panel experience - What their subject matter experts should ask you to ensure alignment - Make confident decisions and avoid costly setbacks in your manufacturing journey. Sign up for our newsletter today to access expert insights and tips straight to your inbox: https://buff.ly/3ZRv6zl #AndelynBiosciences #GeneTherapy #CDMO #Newsletter #AAVCuratorPlatform

Our journey began at Nationwide Children's Hospital, leading to the discovery of the first FDA-approved systemic gene therapy. Today, we stand ready as your reliable partner, equipped with the expertise and scalable solutions to bring your therapies from concept to commercialization. Get in touch and discover how we can contribute to your long-term success with a low risk feasibility study: https://buff.ly/3UzqzNP #andelynbiosciences